» Articles » PMID: 36012670

Functionalized Platinum Nanoparticles with Biomedical Applications

Overview
Journal Int J Mol Sci
Publisher MDPI
Date 2022 Aug 26
PMID 36012670
Authors
Affiliations
Soon will be listed here.
Abstract

Functionalized platinum nanoparticles have been of considerable interest in recent research due to their properties and applications, among which they stand out as therapeutic agents. The functionalization of the surfaces of nanoparticles can overcome the limits of medicine by increasing selectivity and thereby reducing the side effects of conventional drugs. With the constant development of nanotechnology in the biomedical field, functionalized platinum nanoparticles have been used to diagnose and treat diseases such as cancer and infections caused by pathogens. This review reports on physical, chemical, and biological methods of obtaining platinum nanoparticles and the advantages and disadvantages of their synthesis. Additionally, applications in the biomedical field that can be utilized once the surfaces of nanoparticles have been functionalized with different bioactive molecules are discussed, among which antibodies, biodegradable polymers, and biomolecules stand out.

Citing Articles

Biogenic nanoparticles as a promising drug delivery system.

Abdel-Megeed R Toxicol Rep. 2025; 14:101887.

PMID: 39867515 PMC: 11762933. DOI: 10.1016/j.toxrep.2024.101887.


Opportunities and Challenges in the Synthesis of Noble Metal Nanoparticles via the Chemical Route in Microreactor Systems.

Pach A, Szot A, Fitzner K, Luty-Blocho M Micromachines (Basel). 2024; 15(9).

PMID: 39337779 PMC: 11434062. DOI: 10.3390/mi15091119.


An Outlook on Platinum-Based Active Ingredients for Dermatologic and Skincare Applications.

Li S, Liu Y, Wu Y, Ren L, Lu Y, Yamaguchi S Nanomaterials (Basel). 2024; 14(15).

PMID: 39120408 PMC: 11314049. DOI: 10.3390/nano14151303.


Metal nanoparticles for cancer therapy: Precision targeting of DNA damage.

Chen Q, Fang C, Xia F, Wang Q, Li F, Ling D Acta Pharm Sin B. 2024; 14(3):1132-1149.

PMID: 38486992 PMC: 10934341. DOI: 10.1016/j.apsb.2023.08.031.


Resorbable conductive materials for optimally interfacing medical devices with the living.

Sacchi M, Sauter-Starace F, Mailley P, Texier I Front Bioeng Biotechnol. 2024; 12:1294238.

PMID: 38449676 PMC: 10916519. DOI: 10.3389/fbioe.2024.1294238.


References
1.
Zou J, Wang P, Wang Y, Liu G, Zhang Y, Zhang Q . Penetration depth tunable BODIPY derivatives for pH triggered enhanced photothermal/photodynamic synergistic therapy. Chem Sci. 2019; 10(1):268-276. PMC: 6333239. DOI: 10.1039/c8sc02443j. View

2.
Wang J, Tan L, Tan L, Tian Y, Ma J, Tan C . Circulating microRNAs are promising novel biomarkers for drug-resistant epilepsy. Sci Rep. 2015; 5:10201. PMC: 4435024. DOI: 10.1038/srep10201. View

3.
Cardoso M, Peca I, Roque A . Antibody-conjugated nanoparticles for therapeutic applications. Curr Med Chem. 2012; 19(19):3103-27. DOI: 10.2174/092986712800784667. View

4.
Liang P, Tang Q, Cai Y, Liu G, Si W, Shao J . Self-quenched ferrocenyl diketopyrrolopyrrole organic nanoparticles with amplifying photothermal effect for cancer therapy. Chem Sci. 2017; 8(11):7457-7463. PMC: 5674203. DOI: 10.1039/c7sc03351f. View

5.
Alibakhshi A, Kahaki F, Ahangarzadeh S, Yaghoobi H, Yarian F, Arezumand R . Targeted cancer therapy through antibody fragments-decorated nanomedicines. J Control Release. 2017; 268:323-334. DOI: 10.1016/j.jconrel.2017.10.036. View